BCLS ACQUISITION CORP's ticker is BLSA and the CUSIP is G0904B105. A total of 48 filers reported holding BCLS ACQUISITION CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,505,000 | +1.2% | 250,000 | 0.0% | 0.40% | -22.9% |
| Q2 2022 | $2,475,000 | +0.3% | 250,000 | 0.0% | 0.52% | -5.1% |
| Q1 2022 | $2,468,000 | +0.7% | 250,000 | 0.0% | 0.55% | -2.8% |
| Q4 2021 | $2,450,000 | -1.6% | 250,000 | 0.0% | 0.57% | -13.6% |
| Q3 2021 | $2,490,000 | -5.4% | 250,000 | 0.0% | 0.66% | -28.5% |
| Q2 2021 | $2,633,000 | -0.4% | 250,000 | 0.0% | 0.92% | -12.9% |
| Q1 2021 | $2,643,000 | -5.1% | 250,000 | 0.0% | 1.05% | -30.4% |
| Q4 2020 | $2,785,000 | – | 250,000 | – | 1.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 843,122 | $8,322,000 | 3.89% |
| Finepoint Capital LP | 603,429 | $5,956,000 | 1.98% |
| Logan Stone Capital, LLC | 210,276 | $2,075,000 | 1.50% |
| Samsara BioCapital, LLC | 300,000 | $2,961,000 | 0.74% |
| COMMODORE CAPITAL LP | 250,000 | $2,468,000 | 0.55% |
| Bain Capital Life Sciences Investors, LLC | 487,500 | $4,812,000 | 0.47% |
| Altium Capital Management LP | 100,000 | $987,000 | 0.33% |
| Exos Asset Management LLC | 71,039 | $701,000 | 0.30% |
| RA Capital Management | 1,250,000 | $12,338,000 | 0.27% |
| Boxer Capital, LLC | 500,000 | $4,935,000 | 0.25% |